Liaoning Port Co., Ltd. - 2880.HK

2880.HK Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
2880.HK	-1.4	0	-2.8	0	14.8	22.8	-5.4	-26.3	-32.7	-57.8
S&P 500	1.0	1.5	1.1	2.3	8.9	23.6	33.8	80.6	196.5	33856.2

Compare 2880.HK with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	2880.HK
name	Liaoning Port Co., Ltd.
price	0.7
changes percentage	-1.4085
change	-0.01
day low	0.7
day high	0.71
year high	0.84
year low	0.57
market cap	34629524070
price avg 50	0.716
price avg 200	0.65625
exchange	HKSE
volume	847400
avg volume	4723161
open	0.71
previous close	0.71
eps	0.06
pe	11.67
earnings announcement	2025-03-26T10:59:00.000+0000
shares outstanding	49470748671
timestamp	2025-01-20 08:08:32

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 54.3%

Overall Quarterly Financial Health: 13.3%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
revenue	12219878814	11980738429	2.00
gross profit	3390095229	3096868550	9.47
gross profit ratio	0.28	0.26	7.33
research and development expenses	39294670	5687178	590.93
operating expenses	1384745350	800402650	73.01
interest income	74281440	94016449	-20.99
interest expense	501452869	542904055	-7.64
ebitda	4790772408	4756127475	0.73
ebitdaratio	0.39	0.41	-3.52
operating income	2005349878	2598497507	-22.83
operating income ratio	0.16	0.22	-24.34
net income	1343109072	1317655267	1.93
net income ratio	0.11	0.11	-0.06
eps	0.06	0.05	12.00

Overall Score of Annual Income Statement

0.75 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 12,220 million in 2023 from 11,981 million in 2022 representing a change of 2.0%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 3,390 million in 2023 from 3,097 million in 2022 representing a change of 9.47%. This indicates a sales profitability growth, which is a positive sign for the company.

  Operating Expenses: Operating Expenses decreased to 1,385 million in 2023 from 800 million in 2022 representing a change of 73.01%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 4,791 million in 2023 from 4,756 million in 2022 representing a change of 0.73%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Net Income: Net income increased to 1,343 million in 2023 from 1,318 million in 2022 representing a change of 1.93%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 0.06 in 2023 from 0.06 in 2022 representing a change of 12.0%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Research and Development (R&D) Expenses: R&D Expenses decreased to 39 million in 2023 from 6 million in 2022 representing a change of 590.93%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

  Operating Income: Operating income decreased to 2,005 million in 2023 from 2,598 million in 2022 representing a change of -22.83%. The decrease in operating income indicates worse operational performance and decreased profitability.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000000000
revenue	2576214220	2485290858	3.66
gross profit	636563922	430935686	47.72
gross profit ratio	0.25	0.17	42.50
research and development expenses	7267705	4677387	55.38
operating expenses	-23737060.39	165284927	-114.36
interest income	13875067	55104470	-74.82
interest expense	95677962	107203945	-10.75
ebitda	756404890	293372325	157.83
ebitdaratio	0.29	0.11	159.94
operating income	660300982	183155328	260.51
operating income ratio	0.26	0.07	247.79
net income	492064276	81526606	503.56
net income ratio	0.19	0.03	482.26
eps	0.02	0.0	456.76

Overall Score of Quarterly Income Statement

None

Detailed Analysis

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
total assets	56352939728	57609391070	-2.18
total liabilities	13623749088	15867399977	-14.14
total equity	42729190640	41741991092	2.37
cash and cash equivalents	5228415449	5085194083	2.82
short term investments	1	1	0.00
long term investments	3701743609	3930309123	-5.82
total current assets	10116584150	9482788978	6.68
total non current assets	46236355578	48126602091	-3.93
total current liabilities	5181189203	6477798286	-20.02
total non current liabilities	8442559884	9389601691	-10.09
common stock	23987065816	23987065816	0.00
retained earnings	4734941958	3950404277	19.86
total debt	8530659673	12806660617	-33.39

Overall Score of Annual Balance Sheet

0.88 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Total Assets: Total Assets decreased to 56,353 million in 2023 from 57,609 million in 2022 representing a change of -2.18%. Suggesting a decrease in asset holdings.

• 📈 Positive Indicators

  Total Liabilities: Total Liabilities decreased to 13,624 million in 2023 from 15,867 million in 2022 representing a change of -14.14%. This indicates a decrease in overall liabilities.

  Total Equity: Total Equity increased to 42,729 million in 2023 from 41,742 million in 2022 representing a change of 2.37%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 5,228 million in 2023 from 5,085 million in 2022 representing a change of 2.82%. This indicates an increase in available liquid assets.

  Total Current Assets: Total Current Assets increased to 10,117 million in 2023 from 9,483 million in 2022 representing a change of 6.68%. This indicates a better liquidity position.

  Total Current Liabilities: Total Current Liabilities decreased to 5,181 million in 2023 from 6,478 million in 2022 representing a change of -20.02%. This indicates a lower short-term debt burden.

  Retained Earnings: Retained Earnings increased to 4,735 million in 2023 from 3,950 million in 2022 representing a change of 19.86%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 8,531 million in 2023 from 12,807 million in 2022 representing a change of -33.39%. This indicates a reduction in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000000000
total assets	59654629988	54742099716	8.97
total liabilities	15875066249	11916834569	33.22
total equity	43779563738	42825265146	2.23
cash and cash equivalents	4257497020	4431860026	-3.93
short term investments	850000	-295816554	100.29
long term investments	3309978359	3897395186	-15.07
total current assets	9205156598	9574304932	-3.86
total non current assets	50449473390	45167794784	11.69
total current liabilities	5890976722	4627453240	27.30
total non current liabilities	9984089526	7289381329	36.97
common stock	23905474669	23987065816	-0.34
retained earnings	5215284629	4730232346	10.25
total debt	9615534595	9278206884	3.64

Overall Score of Quarterly Balance Sheet

0.4 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 59,655 million in 2024Q3 from 54,742 million in 2024Q2 representing a change of 8.97%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 43,780 million in 2024Q3 from 42,825 million in 2024Q2 representing a change of 2.23%. This indicates an increase in shareholders' equity.

  Short Term Investments: Short Term Investments increased to 1 million in 2024Q3 from -296 million in 2024Q2 representing a change of 100.29%. This indicates an increase in short-term investment holdings.

  Retained Earnings: Retained Earnings increased to 5,215 million in 2024Q3 from 4,730 million in 2024Q2 representing a change of 10.25%. This indicates an accumulated profits.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 15,875 million in 2024Q3 from 11,917 million in 2024Q2 representing a change of 33.22%. This indicates an increase in overall liabilities.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 4,257 million in 2024Q3 from 4,432 million in 2024Q2 representing a change of -3.93%. This indicates a decrease in available liquid assets.

  Total Current Assets: Total Current Assets decreased to 9,205 million in 2024Q3 from 9,574 million in 2024Q2 representing a change of -3.86%. This indicates a worsen liquidity position.

  Total Current Liabilities: Total Current Liabilities increased to 5,891 million in 2024Q3 from 4,627 million in 2024Q2 representing a change of 27.3%. This indicates a higher short-term debt burden.

  Common Stock: Common Stock decreased to 23,905 in 2024Q3 from 23,987 in 2024Q2 representing a change of -0.34%. This indicates a decrease in ownership interest.

  Total Debt: Total Debt increased to 9,616 million in 2024Q3 from 9,278 million in 2024Q2 representing a change of 3.64%. This indicates an increase in overall debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
net change in cash	-46486665	611988075	-107.60
operating cash flow	3339177768	3412304812	-2.14
free cash flow	2671604767	-21573352.36	12483.82
capital expenditure	-667573000	-3433878164.36	80.56
depreciation and amortization	2254326838	2270081130	-0.69
deferred income tax	0	0	NaN
stock based compensation	0	0	NaN
accounts payables	908123395	791489201	14.74
inventory	1578182	-12826481.78	112.30
acquisitions net	0	0	NaN
investments in property plant and equipment	-667573000	-3433878164.36	80.56
net cash used for investing activites	-349145819	-3097176007.73	88.73
debt repayment	-1708000000	2810236702	-160.78
common stock issued	0	0	NaN
common stock repurchased	0	0	NaN
dividends paid	-708712609.91	-859781316.66	17.57
net cash used provided by financing activities	-3028533968	286463801	-1157.21
cash at end of period	5199599767	5045473498	3.05
accounts receivables	-908123395	-791489201	-14.74
cash at beginning of period	5246086432	4433485423	18.33

Overall Score of Annual Cashflow Statement

None

Detailed Analysis

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000000000
operating cash flow	0	994610927	-100.00
free cash flow	-117658765.28	948947163	-112.40
capital expenditure	-117658765.28	-45663763.71	-157.66
depreciation and amortization	0	1130206190	-100.00
deferred income tax	0	0	NaN
stock based compensation	0	0	NaN
accounts receivables	0	-303533858	100.00
accounts payables	0	0	NaN
inventory	0	1985634	-100.00
acquisitions net	0	0	NaN
investments in property plant and equipment	-117658765.28	-45663763.71	-157.66
net cash used for investing activites	13534500	43354980	-68.78
debt repayment	-690000000	-2400000000	71.25
common stock issued	0	0	NaN
common stock repurchased	0	0	NaN
dividends paid	-464174890.45	-123245415.56	-276.63
net cash used provided by financing activities	-1352226772.07	-2803122979.72	51.76
net change in cash	-175666068	-1764371353	90.04
cash at end of period	4215118966	4390785034	-4.00
cash at beginning of period	4390785034	6155156387	-28.66

Overall Score of Quarterly Cashflow Statement

None

Detailed Analysis

Earnings Transcripts ⓘ

No earnings transcripts available.

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	0.51	0.5	2.00
net income per share	0.06	0.05	1.93
operating cash flow per share	0.14	0.14	-2.14
free cash flow per share	0.11	-0.0	12483.82
cash per share	0.22	0.2	6.34
book value per share	1.78	1.74	2.37
tangible book value per share	1.55	1.5	3.17
shareholders equity per share	1.65	1.61	2.47
interest debt per share	0.48	0.56	-14.39
market cap	34781245433.2	38859046621.92	-10.49
enterprise value	40479373980.2	46580513155.92	-13.10
pe ratio	25.9	29.49	-12.19
price to sales ratio	2.85	3.24	-12.25
pocfratio	10.42	11.39	-8.53
pfcf ratio	13.02	-1801.25	100.72
pb ratio	0.88	1.01	-12.65
ptb ratio	0.88	1.01	-12.65
ev to sales	3.31	3.89	-14.80
enterprise value over ebitda	8.45	10.15	-16.78
ev to operating cash flow	12.12	13.65	-11.19
ev to free cash flow	15.15	-2159.17	100.70
earnings yield	0.04	0.03	13.88
free cash flow yield	0.08	-0.0	13935.71
debt to equity	0.28	0.33	-16.74
debt to assets	0.19	0.22	-12.78
net debt to ebitda	1.19	1.68	-29.33
current ratio	1.95	1.46	33.38
interest coverage	4.0	4.79	-16.45
income quality	2.49	2.38	4.29
dividend yield	0.01	0.02	-14.48
payout ratio	0.37	0.49	-24.91
sales general and administrative to revenue	0.06	0.01	326.68
research and ddevelopement to revenue	0.0	0.0	577.41
intangibles to total assets	0.1	0.1	-0.51
capex to operating cash flow	0.2	1.01	-80.13
capex to revenue	0.05	0.29	-80.94
capex to depreciation	0.29	1.51	-80.52
stock based compensation to revenue	0	0	NaN
graham number	1.44	1.41	2.20
roic	0.03	0.04	-23.15
return on tangible assets	0.03	0.03	4.15
graham net net	-0.23	-0.35	34.48
working capital	4935394947	3004990692	64.24
tangible asset value	37153170317	36012310440	3.17
net current asset value	-3507164926	-6384610999	45.07
invested capital	46858620530	46652196090	0.44
average receivables	3658791427.5	3641727983.5	0.47
average payables	333227316	321592738	3.62
average inventory	128610496.5	118858982	8.20
days sales outstanding	115.25	105.38	9.37
days payables outstanding	13.33	14.13	-5.66
days of inventory on hand	5.51	5.09	8.23
receivables turnover	3.17	3.46	-8.57
payables turnover	27.38	25.83	6.00
inventory turnover	66.24	71.69	-7.60
roe	0.03	0.03	-0.53
capex per share	0.03	0.14	-80.56

• Negative

  ROE: Return on Equity (ROE) decreased to 0.03 on 2023-12-31 from 0.03 on 2022-12-31, representing a change of -0.53%. Suggesting that the company has not been generating high returns for its shareholders.

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 25.90 on 2023-12-31 from 29.49 on 2022-12-31, representing a change of -12.19%. Indicating a decrease in the relative valuation of the company's stock.

• Positive

  Current Ratio: Current Ratio increased to 1.95 on 2023-12-31 from 1.46 on 2022-12-31, representing a change of 33.38%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.28 on 2023-12-31 from 0.33 on 2022-12-31, representing a change of -16.74%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Quarterly Financial Ratios

	2024-09-30 Q3	2024-06-30 Q2	Q/Q change %
2880.HK
calendar year	2024	2024	NaN
revenue per share	0.11	0.1	4.01
net income per share	0.02	0.0	505.62
operating cash flow per share	0.05	0.05	11.46
free cash flow per share	0.04	0.04	0.55
cash per share	0.18	0.17	3.31
book value per share	1.83	1.79	2.58
tangible book value per share	1.56	1.56	0.26
shareholders equity per share	1.67	1.65	1.32
interest debt per share	0.41	0.39	3.82
market cap	35619157256.81	30223702928.16	17.85
enterprise value	40977194832.81	35070049786.16	16.84
pe ratio	18.1	92.68	-80.47
price to sales ratio	13.83	12.16	13.69
pocfratio	29.44	27.75	6.10
pfcf ratio	34.06	28.96	17.61
pb ratio	0.89	0.76	16.71
ptb ratio	0.89	0.76	16.71
ev to sales	15.91	14.11	12.72
enterprise value over ebitda	54.17	119.54	-54.68
ev to operating cash flow	33.87	32.2	5.19
ev to free cash flow	39.19	33.61	16.61
earnings yield	0.01	0.0	412.14
free cash flow yield	0.03	0.03	-14.97
debt to equity	0.24	0.23	2.64
debt to assets	0.16	0.17	-4.90
net debt to ebitda	7.08	16.52	-57.12
current ratio	1.56	2.07	-24.48
interest coverage	6.9	1.71	303.94
income quality	2.46	13.36	-81.60
dividend yield	0.01	0.0	219.58
payout ratio	0.94	1.51	-37.60
sales general and administrative to revenue	0.08	0.06	18.29
research and ddevelopement to revenue	0.0	0.0	49.90
intangibles to total assets	0.11	0.1	8.24
capex to operating cash flow	0.1	0.04	131.96
capex to revenue	0.05	0.02	148.57
capex to depreciation	0	0.08	-100.00
stock based compensation to revenue	0	0	NaN
graham number	0.88	0.36	147.71
roic	0.01	0.0	320.28
return on tangible assets	0.01	0.0	458.99
graham net net	-0.34	-0.2	-72.65
working capital	3314179876	4946851692	-33.00
tangible asset value	37305081880	37336042640	-0.08
net current asset value	-6669909651	-2342529637	-184.73
invested capital	49379165583	45838496443	7.72
average receivables	4216265716	4128127449	2.14
average payables	260318231.5	267012235	-2.51
average inventory	133693575	129960190	2.87
days sales outstanding	156.76	142.88	9.71
days payables outstanding	12.22	11.27	8.49
days of inventory on hand	6.31	5.75	9.74
receivables turnover	0.57	0.63	-8.85
payables turnover	7.36	7.99	-7.83
inventory turnover	14.26	15.64	-8.88
roe	0.01	0.0	497.74
capex per share	0.0	0.0	158.54

• Negative

  ROE: Return on Equity (ROE) increased to 0.01 on 2024-09-30 Q3 from 0.00 on 2024-06-30 Q2, representing a change of 497.74%. However, ROE is <= 5%, suggesting that the company has not been generating high returns for its shareholders.

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 18.10 on 2024-09-30 Q3 from 92.68 on 2024-06-30 Q2, representing a change of -80.47%. Indicating a decrease in the relative valuation of the company's stock.

• Neutral

  Current Ratio: Current Ratio decreased to 1.56 on 2024-09-30 Q3 from 2.07 on 2024-06-30 Q2, representing a change of -24.48%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 0.24 on 2024-09-30 Q3 from 0.23 on 2024-06-30 Q2, representing a change of 2.64%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

None